Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease

Journal of Neuropsychology

Volumn 9, Issue 1, 2015, Pages 10-20

  Hart, Ellen P ^a   Dumas, Eve M ^a   Van Zwet, Erik W ^a   Van Der Hiele, Karin ^b   Jurgens, Caroline K ^c   Middelkoop, Huub A M ^a   Van Dijk, J Gert ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

cognition; compensatory mechanisms; Huntington's disease; P300; SART

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLICATION; CROSS-SECTIONAL STUDY; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PILOT STUDY; REACTION TIME;

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; REACTION TIME;

EID: 84923700740     PISSN: 17486645     EISSN: 17486653     Source Type: Journal    
DOI: 10.1111/jnp.12031     Document Type: Article

References (33)

1. Aron, A. R., Watkins, L., Sahakian, B. J., Monsell, S., Barker, R. A., &, Robbins, T. W., (2003). Task-set switching deficits in early-stage Huntington's disease: Implications for basal ganglia function. Journal of Cognitive Neuroscience, 15, 629-642.
2. Beglinger, L. J., Duff, K., Allison, J., Theriault, D., O'Rourke, J. J., Leserman, A.,..., Paulsen, J. S., (2010). Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status. Journal of Clinical and Experimental Neuropsychology, 32, 573-578. doi: 10.1080/13803390903313564
3. Bezard, E., Gross, C. E., &, Brotchie, J. M., (2003). Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends in Neurosciences, 26, 215-221. doi: 10.1016/S0166-2236(03)00038-9
4. Bohanna, I., Georgiou-Karistianis, N., Hannan, A. J., &, Egan, G. F., (2008). Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Research Reviews, 58, 209-225. doi: 10.1016/j.brainresrev.2008.04.001
5. Campodonico, J. R., Codori, A. M., &, Brandt, J., (1996). Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. Journal of Neurology, Neurosurgery and Psychiatry, 61, 621-624. doi: 10.1136/jnnp.61.6.621
6. Craufurd, D., Thompson, J. C., &, Snowden, J. S., (2001). Behavioral changes in Huntington disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14, 219-226. doi: 10.1136/jnnp.61.6.621
7. Datta, A., Cusack, R., Hawkins, K., Heutink, J., Rorden, C., Robertson, I. H.,..., Manly, T., (2007). The P300 as a marker of waning attention and error propensity. Computational Intelligence and Neuroscience, 93968. doi: 10.1155/2007/93968
8. Duff, K., Paulsen, J., Mills, J., Beglinger, L. J., Moser, D. J., Smith, M. M.,..., Harrington, D. L., (2010). Mild cognitive impairment in prediagnosed Huntington disease. Neurology, 75, 500-507. doi: 10.1212/WNL.0b013e3181eccfa2
9. Duncan, C. C., Barry, R. J., Connolly, J. F., Fischer, C., Michie, P. T., Naatanen, R.,..., Van Petten, C., (2009). Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clinical Neurophysiology, 120, 1883-1908. doi: 10.1162/jocn.1989.1.1.38
10. Ehle, A. L., Stewart, R. M., Lellelid, N. A., &, Leventhal, N. A., (1984). Evoked potentials in Huntington's disease. A comparative and longitudinal study. Archives of Neurology, 41, 379-382. doi: 10.1001/archneur.1984.04050160041013
11. Farrow, M., Churchyard, A., Chua, P., Bradshaw, J. L., Chiu, E., &, Georgiou-Karistianis, N., (2007). Attention, inhibition, and proximity to clinical onset in preclinical mutation carriers for Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 29, 235-246. doi: 10.1080/13803390600657693
12. Feigin, A., Ghilardi, M. F., Huang, C., Ma, Y., Carbon, M., Guttman, M.,..., Eidelberg, D., (2006). Preclinical Huntington's disease: Compensatory brain responses during learning. Annals of Neurology, 59, 53-59. doi: 10.1002/ana.20684
13. Folstein, M. F., Folstein, S. E., &, McHugh, P. R., (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
14. Hart, E. P., Dumas, E. M., Reijntjes, R. H., van der Hiele, K., van den Bogaard, S. J., Middelkoop, H. A.,..., Roos, R. A., (2012). Deficient Sustained Attention to Response Task and P300 characteristics in early Huntington's disease. Journal of Neurology, 259, 1191-1198. doi: 10.1371/currents.RRN1288
15. Hart, E., Middelkoop, H., Jurgens, C. K., Witjes-Ane, M. N., &, Roos, R. A,. (2011). Seven-year clinical follow-up of premanifest carriers of Huntington's disease. PLoS Currents HD, 3, RRN1288. doi: 10.1371/currents.RRN1288
16. HDCRG (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group. Cell, 72, 971-983.
17. Huntington Study Group (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Huntington study group. Movement Disorders, 11, 136-142.
18. Kok, A., (1997). Event-related-potential (ERP) reflections of mental resources: A review and synthesis. Biological Psychology, 45, 19-56. doi: 10.1016/S0301-0511(96)05221-0
19. Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., ffrench-Constant, C., Rubinsztein, D. C.,..., Sahakian, B. J., (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121 (7), 1329-1341. doi: 10.1093/brain/121.7.1329
20. Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., &, Dom, R., (2004). Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation-a longitudinal follow-up study. Journal of Neurology, 251, 935-942. doi: 10.1007/s00415-004-0461-9
21. Maroof, D. A., Gross, A. L., &, Brandt, J., (2011). Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 33, 901-909. doi: 10.1080/13803395.2011.574606
22. Muller, S. V., Jung, A., Preinfalk, J., Kolbe, H., Ridao-Alonso, M., Dengler, R.,..., Münte, T. F., (2002). Disturbance of "extrinsic alertness" in Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 24, 517-526. doi: 10.1076/jcen.24.4.517.1043
23. Nguyen, L., Bradshaw, J. L., Stout, J. C., Croft, R. J., &, Georgiou-Karistianis, N., (2010). Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions. Brain Research Reviews, 64, 177-194. doi: 10.1016/j.brainresrev.2010.03.004
24. Peavy, G. M., Jacobson, M. W., Goldstein, J. L., Hamilton, J. M., Kane, A., Gamst, A. C.,..., Corey-Bloom, J., (2010). Cognitive and functional decline in Huntington's disease: Dementia criteria revisited. Movement Disorders, 25, 1163-1169. doi: 10.1002/mds.22953
25. Penney, J. B., Jr., Vonsattel, J. P., MacDonald, M. E., Gusella, J. F., &, Myers, R. H., (1997). CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology, 41, 689-692. doi: 10.1002/ana.410410521
26. Polich, J., &, Criado, J. R., (2006). Neuropsychology and neuropharmacology of P3a and P3b. International Journal of Psychophysiology, 60, 172-185. doi: 10.1016/j.ijpsycho.2005.12.012
27. Robertson, I. H., Manly, T., Andrade, J., Baddeley, B. T., &, Yiend, J., (1997). 'Oops!': Performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia, 35, 747-758. doi: 10.1016/j.neuropsychologia.2010.02.002
28. Samavatyan, H., &, Leth-Steensen, C., (2009). The time course of task switching: A speed-accuracy trade-off analysis. Memory and Cognition, 37, 1051-1058. doi: 10.3758/MC.37.7.1051
29. Tabrizi, S. J., Scahill, R. I., Durr, A., Roos, R. A., Leavitt, B. R., Jones, R.,..., Stout, J. C., (2011). Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurology, 10, 31-42. doi: 10.1016/S1474-4422(10)70276-3
30. van den Bogaard, S., Dumas, E., van der Grond, J., van Buchem, M., &, Roos, R., (2012). MRI biomarkers in Huntington's disease. Frontiers in Bioscience (Elite Edition), 4, 1910-1925.
31. Verny, C., Allain, P., Prudean, A., Malinge, M. C., Gohier, B., Scherer, C.,..., Le Gall, D., (2007). Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. European Journal of Neurology, 14, 1344-1350. doi: 10.1111/j.1468-1331.2007.01975.x
32. Witjes-Ane, M. N., Mertens, B., van Vugt, J. P., Bachoud-Levi, A. C., van Ommen, G. J., &, Roos, R. A., (2007). Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 19, 310-317.
33. Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A., &, Stricker, E. M., (1990). Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends in Neurosciences, 13, 290-296. doi: 10.1016/0166-2236(90)90112-N